About | Followers 12 | Exhibitors | Speakers 30 | Reviews | Deals |
Recent trials have shown both successes and challenges in combining therapies for solid tumors. The FDA Modernization Act 2.0 has steered biopharma towards non-animal models, allowing for innovation in preclinical and translational tumor models. The Annual Tumor Models Boston Summit offers insights from pioneers in preclinical and translational oncology to optimize translatability, efficiency, and cost-effectiveness. Amgen, Angiex, Salarius Pharmaceuticals, and others will share their model selection criteria to streamline the process.
Listed In
Timings09:00 AM-06:00 PM (expected)Not Verified | Entry FeesCheck Official Website |
Estimated Turnout100 - 500 Delegates Based on previous editions | Event TypeConference |
EditionsJul 2024 Interested+12 more editions Frequency Annual | Official LinksWebsiteContactsReport Error Claim this event |
Different Located Editions San Francisco, USA31 Jan - 01 Feb 2024 12 Followers | |
Organizer![]() |
EditionJul 2024
How would you like to participate in this event?
Followers [ Users who have shown interest for this Event ] Join Community Invite
Sort By
Frequently Asked Questions Contact Organizer
Can I get a list of speakers participating in the event?
Can I get a list of exhibitors participating in the event?
Write a Review
Add Your ReviewSpeakers (past edition)
42.345808-71.080896
Venue Map & Directions

120 Huntington Ave, Boston, MA 02116
USA
More Events in Boston
![]() | Women In Tech In Boston Boston, USA |
Oct 172023 | International Conference on CRISPR Technologies Boston, USA |
Oct 192023 | International Lyme And Associated Diseases Society Conference Boston, USA |
Oct 232023 | International Conference on Clinical Immunology and Allergy Boston, USA |
Mar 182024 | PLRB Claims Conference & Insurance Services Expo Boston, USA |